Drug Shortage Report for TRIFLUOPERAZINE

Last updated on 2020-07-23 History
Report ID 119618
Drug Identification Number 00312754
Brand name TRIFLUOPERAZINE
Common or Proper name Trifluoperazine
Company Name AA PHARMA INC
Market Status DORMANT
Active Ingredient(s) TRIFLUOPERAZINE
Strength(s) 2MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100BTL
ATC code N05AB
ATC description ANTIPSYCHOTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-07-07
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2020-07-23
Company comments
Health Canada comments
Contact Address 1165 CREDITSTONE ROAD
VAUGHAN, ONTARIO
CANADA L4K 4N7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2020-07-23 French Compare
v6 2020-07-23 English Compare
v5 2020-07-08 English Compare
v4 2020-07-07 French Compare
v3 2020-07-07 English Compare
v2 2020-07-07 French Compare
v1 2020-07-07 English Compare